{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-27b-text-it",
        "variant": "27b",
        "max_new_tokens": 1024,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_27b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": false,
        "few_shot": true,
        "answer_first": true,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T20:37:26.129224"
  },
  "experiment": "radiology",
  "model": "google/medgemma-27b-text-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 100,
    "incorrect": 0,
    "true_positives": 50,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 0,
    "parse_errors": 0,
    "accuracy": 1.0,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Patient's clinical condition has improved, blood counts are normal, and no signs of malignancy were found on PET-CT. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Patient's clinical condition has improved, blood counts are normal, and no signs of malignancy were found on PET-CT. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T20:38:46.878509"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass\", \"enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, confirmed by imaging findings (posterior fossa mass, enhancement, hydrocephalus, restricted diffusion) and definitive histology (High-grade medulloblastoma). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, confirmed by imaging findings (posterior fossa mass, enhancement, hydrocephalus, restricted diffusion) and definitive histology (High-grade medulloblastoma). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass",
        "enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T20:38:46.878540"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T20:38:46.878557"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, confirmed Burkitt lymphoma on biopsy, presence of abdominal lymphadenopathy, and high LDH levels. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, confirmed Burkitt lymphoma on biopsy, presence of abdominal lymphadenopathy, and high LDH levels. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T20:38:46.878572"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected based on clinical history. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow and immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected based on clinical history. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow and immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T20:38:46.878587"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy with decreasing size, absence of atypical features. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy with decreasing size, absence of atypical features. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T20:38:46.878602"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma strongly indicate malignancy. Staging as Stage III further supports this. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma strongly indicate malignancy. Staging as Stage III further supports this. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T20:38:46.878620"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected based on reason for request, but findings are normal. Supporting evidence: Normal chest radiograph, clear lung fields, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Normal variant or non-malignant condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected based on reason for request, but findings are normal. Supporting evidence: Normal chest radiograph, clear lung fields, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Normal variant or non-malignant condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T20:38:46.878645"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. Contradicting evidence: None identified. Alternative explanations: None needed, findings are normal. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. Contradicting evidence: None identified. Alternative explanations: None needed, findings are normal. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T20:38:46.878663"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as a Wilms Tumor on biopsy with favorable histology and staging. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as a Wilms Tumor on biopsy with favorable histology and staging. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T20:38:46.878677"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of mediastinal lymphadenopathy and a bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of mediastinal lymphadenopathy and a bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T20:38:46.878693"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma, staged as III. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma, staged as III. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T20:38:46.878709"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Hepatoblastoma', describes a 'large heterogeneous hepatic mass', notes 'elevated AFP' (a tumor marker often associated with hepatoblastoma), and assigns a staging classification (PRETEXT stage II). These findings strongly indicate a malignant liver tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Hepatoblastoma', describes a 'large heterogeneous hepatic mass', notes 'elevated AFP' (a tumor marker often associated with hepatoblastoma), and assigns a staging classification (PRETEXT stage II). These findings strongly indicate a malignant liver tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T20:38:46.878725"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Lytic skull lesions with soft tissue component, positive CD1a and Langerin markers, and multisystem disease are highly suggestive of Langerhans Cell Histiocytosis, which is considered a neoplastic disorder. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Lytic skull lesions with soft tissue component, positive CD1a and Langerin markers, and multisystem disease are highly suggestive of Langerhans Cell Histiocytosis, which is considered a neoplastic disorder. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T20:38:46.878740"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request and findings. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, atypical lymphocytes, positive Monospot/EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request and findings. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, atypical lymphocytes, positive Monospot/EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T20:38:46.878756"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70%\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High myeloblast count (70%) and presence of t(8;21) translocation are diagnostic features of Acute Myeloid Leukemia. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High myeloblast count (70%) and presence of t(8;21) translocation are diagnostic features of Acute Myeloid Leukemia. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "myeloblasts 70%",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T20:38:46.878768"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T20:38:46.878781"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, specifically clear lung fields, absence of mediastinal mass, and normal heart size. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, specifically clear lung fields, absence of mediastinal mass, and normal heart size. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T20:38:46.878795"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass\", \"enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, imaging findings (posterior fossa mass with enhancement, hydrocephalus, restricted diffusion), and definitive histology confirming high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, imaging findings (posterior fossa mass with enhancement, hydrocephalus, restricted diffusion), and definitive histology confirming high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass",
        "enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T20:38:46.878809"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, imaging findings of a large suprarenal mass with calcifications and MIBG avidity, and biochemical evidence of elevated urinary catecholamines are highly suggestive of Neuroblastoma. Staging indicates advanced disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, imaging findings of a large suprarenal mass with calcifications and MIBG avidity, and biochemical evidence of elevated urinary catecholamines are highly suggestive of Neuroblastoma. Staging indicates advanced disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T20:38:46.878826"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, imaging findings of a large renal mass, biopsy confirmation of favorable histology, and staging as Stage II. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, imaging findings of a large renal mass, biopsy confirmation of favorable histology, and staging as Stage II. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T20:38:46.878839"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Normal brain MRI findings, explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Normal brain MRI findings, explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T20:38:46.878852"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging showing a large renal mass and biopsy confirming favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging showing a large renal mass and biopsy confirming favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T20:38:46.878883"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation' and 'No malignancy identified'. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation' and 'No malignancy identified'. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T20:38:46.878897"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T20:38:46.878910"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes characteristic features of Ewing Sarcoma, including permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and a positive EWSR1 fusion gene test, which is highly specific for this malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes characteristic features of Ewing Sarcoma, including permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and a positive EWSR1 fusion gene test, which is highly specific for this malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T20:38:46.878926"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, findings of abdominal lymphadenopathy, and confirmation of Burkitt lymphoma on biopsy. High LDH is also consistent with aggressive lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, findings of abdominal lymphadenopathy, and confirmation of Burkitt lymphoma on biopsy. High LDH is also consistent with aggressive lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T20:38:46.878941"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of findings as 'normal process' and 'no pathological features'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of findings as 'normal process' and 'no pathological features'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T20:38:46.878953"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes resolved benign cyst, normal bone density, and no aggressive features. Contradicting evidence: None. Alternative explanations: Resolved benign condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes resolved benign cyst, normal bone density, and no aggressive features. Contradicting evidence: None. Alternative explanations: Resolved benign condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T20:38:46.878967"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity (characteristic of neuroblastoma), elevated urinary catecholamines (biochemical marker), and staging as Stage III disease all strongly support malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity (characteristic of neuroblastoma), elevated urinary catecholamines (biochemical marker), and staging as Stage III disease all strongly support malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T20:38:46.878984"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and histological confirmation of high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and histological confirmation of high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T20:38:46.878998"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest X-ray findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified' by the consultant paediatric oncologist. Contradicting evidence: None identified. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest X-ray findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified' by the consultant paediatric oncologist. Contradicting evidence: None identified. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T20:38:46.879013"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass, elevated tumor markers (AFP and beta-hCG), and identification of yolk sac tumor elements strongly suggest a malignant germ cell tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass, elevated tumor markers (AFP and beta-hCG), and identification of yolk sac tumor elements strongly suggest a malignant germ cell tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T20:38:46.879028"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"palpable mass\", \"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by imaging (ultrasound showing mediastinal lymphadenopathy and mass, PET-CT showing FDG-avid nodes) and pathology (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by imaging (ultrasound showing mediastinal lymphadenopathy and mass, PET-CT showing FDG-avid nodes) and pathology (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "palpable mass",
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T20:38:46.879044"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, no blast cells, adequate platelets, normal hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None, findings are normal. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, no blast cells, adequate platelets, normal hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None, findings are normal. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T20:38:46.879059"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected. Supporting evidence: CT scan findings describe a benign lipoma, which is a non-cancerous fatty tumor. Features like being well-circumscribed and showing no enhancement further support a benign nature. The report explicitly states 'No malignancy identified' and 'Reassurance provided'. Contradicting evidence: None. Alternative explanations: The soft tissue mass is a lipoma, a common benign condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected. Supporting evidence: CT scan findings describe a benign lipoma, which is a non-cancerous fatty tumor. Features like being well-circumscribed and showing no enhancement further support a benign nature. The report explicitly states 'No malignancy identified' and 'Reassurance provided'. Contradicting evidence: None. Alternative explanations: The soft tissue mass is a lipoma, a common benign condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T20:38:46.879076"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T20:38:46.879089"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive lesion with soft tissue component and characteristic sunburst periosteal reaction on imaging, elevated alkaline phosphatase. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive lesion with soft tissue component and characteristic sunburst periosteal reaction on imaging, elevated alkaline phosphatase. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T20:38:46.879104"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive bone lesion with soft tissue involvement, characteristic sunburst periosteal reaction, and elevated alkaline phosphatase (often associated with bone turnover/malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive bone lesion with soft tissue involvement, characteristic sunburst periosteal reaction, and elevated alkaline phosphatase (often associated with bone turnover/malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T20:38:46.879120"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral process (lymphocytosis, atypical lymphocytes resolving, positive Monospot and EBV serology). Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral process (lymphocytosis, atypical lymphocytes resolving, positive Monospot and EBV serology). Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T20:38:46.879134"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Wilms Tumor\", \"Favorable histology\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as Wilms Tumor, a pediatric kidney cancer. Stage II indicates localized disease. Contradicting evidence: None identified. Alternative explanations: While a mass is present, the diagnosis is specifically Wilms Tumor, a malignancy. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as Wilms Tumor, a pediatric kidney cancer. Stage II indicates localized disease. Contradicting evidence: None identified. Alternative explanations: While a mass is present, the diagnosis is specifically Wilms Tumor, a malignancy. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Wilms Tumor",
        "Favorable histology",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T20:38:46.879148"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by findings of mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by findings of mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T20:38:46.879163"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral infection (likely EBV/mono) with resolving atypical lymphocytes and positive serology. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to viral infection. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral infection (likely EBV/mono) with resolving atypical lymphocytes and positive serology. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to viral infection. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T20:38:46.879178"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T20:38:46.879191"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction are classic signs of Ewing Sarcoma. EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. Clinical suspicion of Ewing Sarcoma is noted. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction are classic signs of Ewing Sarcoma. EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. Clinical suspicion of Ewing Sarcoma is noted. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T20:38:46.879207"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', normal MRI findings. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', normal MRI findings. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T20:38:46.879219"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on screening context and findings. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Benign', 'Physiological splenomegaly for age', 'Normal echo texture', and absence of 'focal lesions'. Contradicting evidence: None. Alternative explanations: Physiological splenomegaly is a normal variant. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on screening context and findings. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Benign', 'Physiological splenomegaly for age', 'Normal echo texture', and absence of 'focal lesions'. Contradicting evidence: None. Alternative explanations: Physiological splenomegaly is a normal variant. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T20:38:46.879234"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T20:38:46.879249"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"suspected Osteosarcoma\", \"Osteosarcoma mentioned in clinical notes\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly mentions 'suspected Osteosarcoma' and 'Osteosarcoma' in clinical notes. Findings like a 'destructive lesion' with a 'soft tissue component' and a 'sunburst periosteal reaction' are highly characteristic radiological signs of osteosarcoma, a primary bone malignancy. Contradicting evidence: None identified in the provided report. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly mentions 'suspected Osteosarcoma' and 'Osteosarcoma' in clinical notes. Findings like a 'destructive lesion' with a 'soft tissue component' and a 'sunburst periosteal reaction' are highly characteristic radiological signs of osteosarcoma, a primary bone malignancy. Contradicting evidence: None identified in the provided report. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "suspected Osteosarcoma",
        "Osteosarcoma mentioned in clinical notes"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T20:38:46.879266"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy explanation, decreasing node size, absence of atypical features. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy explanation, decreasing node size, absence of atypical features. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T20:38:46.879281"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, clear lungs, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, clear lungs, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T20:38:46.879295"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified' and confirms a benign lipoma. Contradicting evidence: None. Alternative explanations: The findings are consistent with a benign lipoma, a common fatty tumor. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified' and confirms a benign lipoma. Contradicting evidence: None. Alternative explanations: The findings are consistent with a benign lipoma, a common fatty tumor. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T20:38:46.879308"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging finding of a large renal mass and biopsy showing favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging finding of a large renal mass and biopsy showing favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T20:38:46.879322"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes reactive lymphadenopathy likely due to viral infection, and notes decreasing node size. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes reactive lymphadenopathy likely due to viral infection, and notes decreasing node size. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T20:38:46.879336"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\", \"Suspected Hepatoblastoma\", \"Hepatoblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hepatoblastoma, presence of a large hepatic mass, elevated AFP, specific histology subtype, and staging information (PRETEXT II) all strongly indicate malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hepatoblastoma, presence of a large hepatic mass, elevated AFP, specific histology subtype, and staging information (PRETEXT II) all strongly indicate malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II",
        "Suspected Hepatoblastoma",
        "Hepatoblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T20:38:46.879350"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal imaging findings (chest radiograph, clear lungs, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal imaging findings (chest radiograph, clear lungs, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T20:38:46.879374"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state 'No malignancy identified', 'Reactive lymphadenopathy secondary to viral infection', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state 'No malignancy identified', 'Reactive lymphadenopathy secondary to viral infection', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T20:38:46.879389"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and histological confirmation of yolk sac tumor elements. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and histological confirmation of yolk sac tumor elements. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T20:38:46.879403"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and identification of yolk sac tumor elements are highly suggestive of a germ cell tumor, which is a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and identification of yolk sac tumor elements are highly suggestive of a germ cell tumor, which is a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T20:38:46.879417"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Biopsy confirms Embryonal rhabdomyosarcoma, a malignant tumor. Presence of a parameningeal mass with intracranial extension further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Biopsy confirms Embryonal rhabdomyosarcoma, a malignant tumor. Presence of a parameningeal mass with intracranial extension further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T20:38:46.879430"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T20:38:46.879444"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, positive Monospot, confirmed EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, positive Monospot, confirmed EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T20:38:46.879457"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Report explicitly states 'No malignancy identified', 'No atypical features', and lymphadenopathy is reactive and decreasing. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Report explicitly states 'No malignancy identified', 'No atypical features', and lymphadenopathy is reactive and decreasing. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T20:38:46.879471"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Routine surveillance\", \"No previous oncology history\", \"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on routine surveillance context. Supporting evidence: Explicit statement 'No malignancy identified', normalized blood counts, clinical improvement, and lack of prior oncology history. Contradicting evidence: None. Alternative explanations: Resolved febrile illness. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on routine surveillance context. Supporting evidence: Explicit statement 'No malignancy identified', normalized blood counts, clinical improvement, and lack of prior oncology history. Contradicting evidence: None. Alternative explanations: Resolved febrile illness. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Routine surveillance",
        "No previous oncology history",
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T20:38:46.879487"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Reactive lymphadenopathy secondary to viral infection', notes decreasing node size, and mentions 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Reactive lymphadenopathy secondary to viral infection', notes decreasing node size, and mentions 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T20:38:46.879503"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T20:38:46.879516"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, all characteristic features of neuroblastoma. The clinical notes explicitly state 'Neuroblastoma' and 'Paediatric oncology assessment', and the report confirms Stage III disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, all characteristic features of neuroblastoma. The clinical notes explicitly state 'Neuroblastoma' and 'Paediatric oncology assessment', and the report confirms Stage III disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T20:38:46.879533"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, absence of blast cells, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, absence of blast cells, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T20:38:46.879547"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, biopsy confirms Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, biopsy confirms Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T20:38:46.879559"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings (clear lungs, no mass, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None needed given the negative findings. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings (clear lungs, no mass, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None needed given the negative findings. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T20:38:46.879573"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Intraocular mass with calcifications, bilateral disease, positive family history, and detected RB1 germline mutation are highly suggestive of Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Intraocular mass with calcifications, bilateral disease, positive family history, and detected RB1 germline mutation are highly suggestive of Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T20:38:46.879586"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, abnormal imaging (mediastinal lymphadenopathy, bulky mass), PET-CT findings (FDG-avid nodes), and histological classification (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, abnormal imaging (mediastinal lymphadenopathy, bulky mass), PET-CT findings (FDG-avid nodes), and histological classification (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T20:38:46.879600"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension, and biopsy confirmation of Embryonal rhabdomyosarcoma. Contradicting evidence: PAX-FOXO1 fusion negative (this is a prognostic factor, not contradicting malignancy itself). Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension, and biopsy confirmation of Embryonal rhabdomyosarcoma. Contradicting evidence: PAX-FOXO1 fusion negative (this is a prognostic factor, not contradicting malignancy itself). Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T20:38:46.879614"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Ultrasound findings describe physiological splenomegaly, normal echo texture, and explicitly state 'No malignancy identified'. Contradicting evidence: None identified. Alternative explanations: Splenomegaly is described as physiological for age. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Ultrasound findings describe physiological splenomegaly, normal echo texture, and explicitly state 'No malignancy identified'. Contradicting evidence: None identified. Alternative explanations: Splenomegaly is described as physiological for age. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T20:38:46.879628"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\", \"Paediatric oncology assessment\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Ewing Sarcoma, permeative bone destruction, large soft tissue mass, characteristic onion-skin periosteal reaction, and positive EWSR1 fusion gene test are all highly indicative of Ewing Sarcoma, a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Ewing Sarcoma, permeative bone destruction, large soft tissue mass, characteristic onion-skin periosteal reaction, and positive EWSR1 fusion gene test are all highly indicative of Ewing Sarcoma, a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma",
        "Paediatric oncology assessment"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T20:38:46.879644"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T20:38:46.879658"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets, normal hemoglobin, and explicit statement of no malignancy identified. Contradicting evidence: None. Alternative explanations: None suggested. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets, normal hemoglobin, and explicit statement of no malignancy identified. Contradicting evidence: None. Alternative explanations: None suggested. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T20:38:46.879671"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of 'Healing fracture - normal process', and absence of 'pathological features'. Contradicting evidence: None. Alternative explanations: Healing fracture due to trauma. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of 'Healing fracture - normal process', and absence of 'pathological features'. Contradicting evidence: None. Alternative explanations: Healing fracture due to trauma. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T20:38:46.879685"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Suspected Acute Lymphoblastic Leukemia\", \"Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow, immunophenotyping consistent with B-cell ALL, and clinical suspicion/diagnosis of Acute Lymphoblastic Leukemia. Contradicting evidence: CNS involvement negative (this doesn't contradict malignancy, but indicates limited spread at this point). Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow, immunophenotyping consistent with B-cell ALL, and clinical suspicion/diagnosis of Acute Lymphoblastic Leukemia. Contradicting evidence: CNS involvement negative (this doesn't contradict malignancy, but indicates limited spread at this point). Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Suspected Acute Lymphoblastic Leukemia",
        "Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T20:38:46.879701"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on screening context. Supporting evidence: Findings indicate a resolving viral infection (likely EBV/mononucleosis) with lymphocytosis and atypical lymphocytes. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to infection. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on screening context. Supporting evidence: Findings indicate a resolving viral infection (likely EBV/mononucleosis) with lymphocytosis and atypical lymphocytes. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to infection. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T20:38:46.879716"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No focal lesions\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on benign presentation. Supporting evidence: Explicit statement 'No malignancy identified', benign presentation, no focal lesions. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on benign presentation. Supporting evidence: Explicit statement 'No malignancy identified', benign presentation, no focal lesions. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign presentation",
        "No focal lesions",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T20:38:46.879728"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Findings confirm a benign lipoma with characteristics (well-circumscribed, no enhancement) inconsistent with malignancy. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Findings confirm a benign lipoma with characteristics (well-circumscribed, no enhancement) inconsistent with malignancy. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T20:38:46.879743"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Suspected Wilms Tumor' and confirms 'Favorable histology on biopsy' of a 'large heterogeneous left renal mass', which is consistent with a malignant renal tumor in a pediatric patient. The staging as 'Stage II' further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Suspected Wilms Tumor' and confirms 'Favorable histology on biopsy' of a 'large heterogeneous left renal mass', which is consistent with a malignant renal tumor in a pediatric patient. The staging as 'Stage II' further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T20:38:46.879758"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\", \"Paediatric oncology assessment\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, imaging findings (destructive lesion, soft tissue component, sunburst periosteal reaction), and elevated alkaline phosphatase are highly suggestive of a primary bone malignancy, specifically Osteosarcoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, imaging findings (destructive lesion, soft tissue component, sunburst periosteal reaction), and elevated alkaline phosphatase are highly suggestive of a primary bone malignancy, specifically Osteosarcoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma",
        "Paediatric oncology assessment"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T20:38:46.879774"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No previous oncology history\", \"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and reason for request. Supporting evidence: History indicates a benign presentation with no prior oncology issues. MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. The healing fracture is described as a 'normal process' consistent with trauma history. Reassurance was provided. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and reason for request. Supporting evidence: History indicates a benign presentation with no prior oncology issues. MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. The healing fracture is described as a 'normal process' consistent with trauma history. Reassurance was provided. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign presentation",
        "No previous oncology history",
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T20:38:46.879790"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified' along with normal findings on chest radiograph (clear lungs, normal heart size, no mass). Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified' along with normal findings on chest radiograph (clear lungs, normal heart size, no mass). Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T20:38:46.879803"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large hepatic mass, elevated AFP (a tumor marker), and the explicit mention of 'Hepatoblastoma' (a malignant liver tumor). The fetal histology subtype and PRETEXT staging further support a malignant diagnosis. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large hepatic mass, elevated AFP (a tumor marker), and the explicit mention of 'Hepatoblastoma' (a malignant liver tumor). The fetal histology subtype and PRETEXT staging further support a malignant diagnosis. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T20:38:46.879818"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70%\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of myeloblasts (70%) in the bone marrow and the presence of a specific chromosomal translocation t(8;21), both strongly indicative of Acute Myeloid Leukemia (AML). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of myeloblasts (70%) in the bone marrow and the presence of a specific chromosomal translocation t(8;21), both strongly indicative of Acute Myeloid Leukemia (AML). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "myeloblasts 70%",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T20:38:46.879830"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Wilms Tumor', a known pediatric malignancy, and describes a 'large heterogeneous left renal mass'. The staging (Stage II) and histology (Favorable) further support a diagnosis of cancer. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Wilms Tumor', a known pediatric malignancy, and describes a 'large heterogeneous left renal mass'. The staging (Stage II) and histology (Favorable) further support a diagnosis of cancer. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T20:38:46.879844"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage (85%) of lymphoblasts in bone marrow, immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage (85%) of lymphoblasts in bone marrow, immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T20:38:46.879856"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T20:38:46.879881"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation'. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation'. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T20:38:46.879893"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Benign bone cyst - resolved', 'No aggressive features', 'Normal bone density', 'No recurrence on imaging'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Benign bone cyst - resolved', 'No aggressive features', 'Normal bone density', 'No recurrence on imaging'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T20:38:46.879907"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and findings. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and findings. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T20:38:46.879927"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected but findings are normal. Supporting evidence: Normal brain MRI with no mass lesions or abnormal enhancement. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected but findings are normal. Supporting evidence: Normal brain MRI with no mass lesions or abnormal enhancement. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T20:38:46.879946"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and lack of history. Supporting evidence: MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Healing fracture is a normal process, consistent with trauma history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and lack of history. Supporting evidence: MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Healing fracture is a normal process, consistent with trauma history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T20:38:46.879964"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"palpable mass\", \"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of palpable mass, mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological confirmation of Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of palpable mass, mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological confirmation of Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "palpable mass",
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T20:38:46.879986"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected based on clinical notes and imaging findings. Supporting evidence: Imaging shows an infiltrative mass with mass effect and FLAIR hyperintensity, consistent with a tumor. Biopsy confirms a diffuse astrocytoma, which is a type of brain tumor (malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected based on clinical notes and imaging findings. Supporting evidence: Imaging shows an infiltrative mass with mass effect and FLAIR hyperintensity, consistent with a tumor. Biopsy confirms a diffuse astrocytoma, which is a type of brain tumor (malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T20:38:46.880004"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets and hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets and hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T20:38:46.880021"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Mediastinal lymphadenopathy, bulky mass, FDG avidity, and specific histological type (Classical Hodgkin, nodular sclerosing) strongly indicate Hodgkin Lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Mediastinal lymphadenopathy, bulky mass, FDG avidity, and specific histological type (Classical Hodgkin, nodular sclerosing) strongly indicate Hodgkin Lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T20:38:46.880040"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Patient's clinical condition has improved, blood counts are normal, and no signs of malignancy were found on PET-CT. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Patient's clinical condition has improved, blood counts are normal, and no signs of malignancy were found on PET-CT. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T20:38:46.878509"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass\", \"enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, confirmed by imaging findings (posterior fossa mass, enhancement, hydrocephalus, restricted diffusion) and definitive histology (High-grade medulloblastoma). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, confirmed by imaging findings (posterior fossa mass, enhancement, hydrocephalus, restricted diffusion) and definitive histology (High-grade medulloblastoma). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass",
        "enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T20:38:46.878540"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T20:38:46.878557"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, confirmed Burkitt lymphoma on biopsy, presence of abdominal lymphadenopathy, and high LDH levels. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, confirmed Burkitt lymphoma on biopsy, presence of abdominal lymphadenopathy, and high LDH levels. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T20:38:46.878572"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected based on clinical history. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow and immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected based on clinical history. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow and immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T20:38:46.878587"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy with decreasing size, absence of atypical features. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy with decreasing size, absence of atypical features. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T20:38:46.878602"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma strongly indicate malignancy. Staging as Stage III further supports this. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma strongly indicate malignancy. Staging as Stage III further supports this. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T20:38:46.878620"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected based on reason for request, but findings are normal. Supporting evidence: Normal chest radiograph, clear lung fields, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Normal variant or non-malignant condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected based on reason for request, but findings are normal. Supporting evidence: Normal chest radiograph, clear lung fields, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Normal variant or non-malignant condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T20:38:46.878645"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. Contradicting evidence: None identified. Alternative explanations: None needed, findings are normal. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, and absence of blast cells. Contradicting evidence: None identified. Alternative explanations: None needed, findings are normal. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T20:38:46.878663"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as a Wilms Tumor on biopsy with favorable histology and staging. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as a Wilms Tumor on biopsy with favorable histology and staging. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T20:38:46.878677"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of mediastinal lymphadenopathy and a bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of mediastinal lymphadenopathy and a bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T20:38:46.878693"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma, staged as III. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and clinical suspicion/diagnosis of Neuroblastoma, staged as III. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T20:38:46.878709"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Hepatoblastoma', describes a 'large heterogeneous hepatic mass', notes 'elevated AFP' (a tumor marker often associated with hepatoblastoma), and assigns a staging classification (PRETEXT stage II). These findings strongly indicate a malignant liver tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Hepatoblastoma', describes a 'large heterogeneous hepatic mass', notes 'elevated AFP' (a tumor marker often associated with hepatoblastoma), and assigns a staging classification (PRETEXT stage II). These findings strongly indicate a malignant liver tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T20:38:46.878725"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Lytic skull lesions with soft tissue component, positive CD1a and Langerin markers, and multisystem disease are highly suggestive of Langerhans Cell Histiocytosis, which is considered a neoplastic disorder. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Lytic skull lesions with soft tissue component, positive CD1a and Langerin markers, and multisystem disease are highly suggestive of Langerhans Cell Histiocytosis, which is considered a neoplastic disorder. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T20:38:46.878740"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request and findings. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, atypical lymphocytes, positive Monospot/EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request and findings. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, atypical lymphocytes, positive Monospot/EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T20:38:46.878756"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70%\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High myeloblast count (70%) and presence of t(8;21) translocation are diagnostic features of Acute Myeloid Leukemia. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High myeloblast count (70%) and presence of t(8;21) translocation are diagnostic features of Acute Myeloid Leukemia. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "myeloblasts 70%",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T20:38:46.878768"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, confirmed by biopsy showing Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T20:38:46.878781"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, specifically clear lung fields, absence of mediastinal mass, and normal heart size. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, specifically clear lung fields, absence of mediastinal mass, and normal heart size. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T20:38:46.878795"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass\", \"enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, imaging findings (posterior fossa mass with enhancement, hydrocephalus, restricted diffusion), and definitive histology confirming high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of medulloblastoma, imaging findings (posterior fossa mass with enhancement, hydrocephalus, restricted diffusion), and definitive histology confirming high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass",
        "enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T20:38:46.878809"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, imaging findings of a large suprarenal mass with calcifications and MIBG avidity, and biochemical evidence of elevated urinary catecholamines are highly suggestive of Neuroblastoma. Staging indicates advanced disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, imaging findings of a large suprarenal mass with calcifications and MIBG avidity, and biochemical evidence of elevated urinary catecholamines are highly suggestive of Neuroblastoma. Staging indicates advanced disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T20:38:46.878826"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, imaging findings of a large renal mass, biopsy confirmation of favorable histology, and staging as Stage II. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, imaging findings of a large renal mass, biopsy confirmation of favorable histology, and staging as Stage II. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T20:38:46.878839"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Normal brain MRI findings, explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Normal brain MRI findings, explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T20:38:46.878852"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging showing a large renal mass and biopsy confirming favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging showing a large renal mass and biopsy confirming favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T20:38:46.878883"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation' and 'No malignancy identified'. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation' and 'No malignancy identified'. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T20:38:46.878897"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T20:38:46.878910"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes characteristic features of Ewing Sarcoma, including permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and a positive EWSR1 fusion gene test, which is highly specific for this malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes characteristic features of Ewing Sarcoma, including permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and a positive EWSR1 fusion gene test, which is highly specific for this malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T20:38:46.878926"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, findings of abdominal lymphadenopathy, and confirmation of Burkitt lymphoma on biopsy. High LDH is also consistent with aggressive lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Non-Hodgkin Lymphoma, findings of abdominal lymphadenopathy, and confirmation of Burkitt lymphoma on biopsy. High LDH is also consistent with aggressive lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T20:38:46.878941"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of findings as 'normal process' and 'no pathological features'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of findings as 'normal process' and 'no pathological features'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T20:38:46.878953"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes resolved benign cyst, normal bone density, and no aggressive features. Contradicting evidence: None. Alternative explanations: Resolved benign condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes resolved benign cyst, normal bone density, and no aggressive features. Contradicting evidence: None. Alternative explanations: Resolved benign condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T20:38:46.878967"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity (characteristic of neuroblastoma), elevated urinary catecholamines (biochemical marker), and staging as Stage III disease all strongly support malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Neuroblastoma, presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity (characteristic of neuroblastoma), elevated urinary catecholamines (biochemical marker), and staging as Stage III disease all strongly support malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T20:38:46.878984"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and histological confirmation of high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and histological confirmation of high-grade medulloblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T20:38:46.878998"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest X-ray findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified' by the consultant paediatric oncologist. Contradicting evidence: None identified. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest X-ray findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified' by the consultant paediatric oncologist. Contradicting evidence: None identified. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T20:38:46.879013"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass, elevated tumor markers (AFP and beta-hCG), and identification of yolk sac tumor elements strongly suggest a malignant germ cell tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass, elevated tumor markers (AFP and beta-hCG), and identification of yolk sac tumor elements strongly suggest a malignant germ cell tumor. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T20:38:46.879028"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"palpable mass\", \"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by imaging (ultrasound showing mediastinal lymphadenopathy and mass, PET-CT showing FDG-avid nodes) and pathology (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by imaging (ultrasound showing mediastinal lymphadenopathy and mass, PET-CT showing FDG-avid nodes) and pathology (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "palpable mass",
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T20:38:46.879044"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, no blast cells, adequate platelets, normal hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None, findings are normal. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, no blast cells, adequate platelets, normal hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None, findings are normal. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T20:38:46.879059"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected. Supporting evidence: CT scan findings describe a benign lipoma, which is a non-cancerous fatty tumor. Features like being well-circumscribed and showing no enhancement further support a benign nature. The report explicitly states 'No malignancy identified' and 'Reassurance provided'. Contradicting evidence: None. Alternative explanations: The soft tissue mass is a lipoma, a common benign condition. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected. Supporting evidence: CT scan findings describe a benign lipoma, which is a non-cancerous fatty tumor. Features like being well-circumscribed and showing no enhancement further support a benign nature. The report explicitly states 'No malignancy identified' and 'Reassurance provided'. Contradicting evidence: None. Alternative explanations: The soft tissue mass is a lipoma, a common benign condition. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T20:38:46.879076"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, including clear lungs, normal heart size, and absence of mediastinal mass. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T20:38:46.879089"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive lesion with soft tissue component and characteristic sunburst periosteal reaction on imaging, elevated alkaline phosphatase. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive lesion with soft tissue component and characteristic sunburst periosteal reaction on imaging, elevated alkaline phosphatase. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T20:38:46.879104"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive bone lesion with soft tissue involvement, characteristic sunburst periosteal reaction, and elevated alkaline phosphatase (often associated with bone turnover/malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, presence of a destructive bone lesion with soft tissue involvement, characteristic sunburst periosteal reaction, and elevated alkaline phosphatase (often associated with bone turnover/malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T20:38:46.879120"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral process (lymphocytosis, atypical lymphocytes resolving, positive Monospot and EBV serology). Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral process (lymphocytosis, atypical lymphocytes resolving, positive Monospot and EBV serology). Contradicting evidence: None. Alternative explanations: Infectious mononucleosis. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T20:38:46.879134"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Wilms Tumor\", \"Favorable histology\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as Wilms Tumor, a pediatric kidney cancer. Stage II indicates localized disease. Contradicting evidence: None identified. Alternative explanations: While a mass is present, the diagnosis is specifically Wilms Tumor, a malignancy. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large renal mass identified as Wilms Tumor, a pediatric kidney cancer. Stage II indicates localized disease. Contradicting evidence: None identified. Alternative explanations: While a mass is present, the diagnosis is specifically Wilms Tumor, a malignancy. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Wilms Tumor",
        "Favorable histology",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T20:38:46.879148"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by findings of mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, confirmed by findings of mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological classification as Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T20:38:46.879163"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral infection (likely EBV/mono) with resolving atypical lymphocytes and positive serology. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to viral infection. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Findings indicate a post-viral infection (likely EBV/mono) with resolving atypical lymphocytes and positive serology. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to viral infection. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T20:38:46.879178"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected. Supporting evidence: Normal brain MRI, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T20:38:46.879191"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction are classic signs of Ewing Sarcoma. EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. Clinical suspicion of Ewing Sarcoma is noted. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction are classic signs of Ewing Sarcoma. EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. Clinical suspicion of Ewing Sarcoma is noted. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T20:38:46.879207"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', normal MRI findings. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', normal MRI findings. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T20:38:46.879219"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on screening context and findings. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Benign', 'Physiological splenomegaly for age', 'Normal echo texture', and absence of 'focal lesions'. Contradicting evidence: None. Alternative explanations: Physiological splenomegaly is a normal variant. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on screening context and findings. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Benign', 'Physiological splenomegaly for age', 'Normal echo texture', and absence of 'focal lesions'. Contradicting evidence: None. Alternative explanations: Physiological splenomegaly is a normal variant. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T20:38:46.879234"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T20:38:46.879249"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"suspected Osteosarcoma\", \"Osteosarcoma mentioned in clinical notes\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly mentions 'suspected Osteosarcoma' and 'Osteosarcoma' in clinical notes. Findings like a 'destructive lesion' with a 'soft tissue component' and a 'sunburst periosteal reaction' are highly characteristic radiological signs of osteosarcoma, a primary bone malignancy. Contradicting evidence: None identified in the provided report. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly mentions 'suspected Osteosarcoma' and 'Osteosarcoma' in clinical notes. Findings like a 'destructive lesion' with a 'soft tissue component' and a 'sunburst periosteal reaction' are highly characteristic radiological signs of osteosarcoma, a primary bone malignancy. Contradicting evidence: None identified in the provided report. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "suspected Osteosarcoma",
        "Osteosarcoma mentioned in clinical notes"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T20:38:46.879266"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy explanation, decreasing node size, absence of atypical features. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Explicit statement 'No malignancy identified', reactive lymphadenopathy explanation, decreasing node size, absence of atypical features. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T20:38:46.879281"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, clear lungs, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings, clear lungs, no mediastinal mass, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in case history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T20:38:46.879295"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified' and confirms a benign lipoma. Contradicting evidence: None. Alternative explanations: The findings are consistent with a benign lipoma, a common fatty tumor. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified' and confirms a benign lipoma. Contradicting evidence: None. Alternative explanations: The findings are consistent with a benign lipoma, a common fatty tumor. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T20:38:46.879308"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging finding of a large renal mass and biopsy showing favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Wilms Tumor, confirmed by imaging finding of a large renal mass and biopsy showing favorable histology. Stage II indicates a localized malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T20:38:46.879322"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes reactive lymphadenopathy likely due to viral infection, and notes decreasing node size. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes reactive lymphadenopathy likely due to viral infection, and notes decreasing node size. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T20:38:46.879336"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\", \"Suspected Hepatoblastoma\", \"Hepatoblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hepatoblastoma, presence of a large hepatic mass, elevated AFP, specific histology subtype, and staging information (PRETEXT II) all strongly indicate malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hepatoblastoma, presence of a large hepatic mass, elevated AFP, specific histology subtype, and staging information (PRETEXT II) all strongly indicate malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II",
        "Suspected Hepatoblastoma",
        "Hepatoblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T20:38:46.879350"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal imaging findings (chest radiograph, clear lungs, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and findings. Supporting evidence: Normal imaging findings (chest radiograph, clear lungs, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Benign presentation as stated in history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T20:38:46.879374"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state 'No malignancy identified', 'Reactive lymphadenopathy secondary to viral infection', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state 'No malignancy identified', 'Reactive lymphadenopathy secondary to viral infection', 'Node size decreasing', and 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T20:38:46.879389"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and histological confirmation of yolk sac tumor elements. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and histological confirmation of yolk sac tumor elements. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T20:38:46.879403"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and identification of yolk sac tumor elements are highly suggestive of a germ cell tumor, which is a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a sacrococcygeal mass with solid/cystic components, elevated tumor markers (AFP, beta-hCG), and identification of yolk sac tumor elements are highly suggestive of a germ cell tumor, which is a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T20:38:46.879417"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Biopsy confirms Embryonal rhabdomyosarcoma, a malignant tumor. Presence of a parameningeal mass with intracranial extension further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Biopsy confirms Embryonal rhabdomyosarcoma, a malignant tumor. Presence of a parameningeal mass with intracranial extension further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T20:38:46.879430"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Normal brain MRI findings, absence of mass lesions or abnormal enhancement, and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T20:38:46.879444"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, positive Monospot, confirmed EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings consistent with infectious mononucleosis (post-viral lymphocytosis, positive Monospot, confirmed EBV). Explicit statement 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T20:38:46.879457"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Report explicitly states 'No malignancy identified', 'No atypical features', and lymphadenopathy is reactive and decreasing. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Report explicitly states 'No malignancy identified', 'No atypical features', and lymphadenopathy is reactive and decreasing. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T20:38:46.879471"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Routine surveillance\", \"No previous oncology history\", \"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on routine surveillance context. Supporting evidence: Explicit statement 'No malignancy identified', normalized blood counts, clinical improvement, and lack of prior oncology history. Contradicting evidence: None. Alternative explanations: Resolved febrile illness. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on routine surveillance context. Supporting evidence: Explicit statement 'No malignancy identified', normalized blood counts, clinical improvement, and lack of prior oncology history. Contradicting evidence: None. Alternative explanations: Resolved febrile illness. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Routine surveillance",
        "No previous oncology history",
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T20:38:46.879487"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Reactive lymphadenopathy secondary to viral infection', notes decreasing node size, and mentions 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', describes findings as 'Reactive lymphadenopathy secondary to viral infection', notes decreasing node size, and mentions 'No atypical features'. Contradicting evidence: None. Alternative explanations: Viral infection causing reactive lymphadenopathy. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T20:38:46.879503"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T20:38:46.879516"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, all characteristic features of neuroblastoma. The clinical notes explicitly state 'Neuroblastoma' and 'Paediatric oncology assessment', and the report confirms Stage III disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, all characteristic features of neuroblastoma. The clinical notes explicitly state 'Neuroblastoma' and 'Paediatric oncology assessment', and the report confirms Stage III disease. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T20:38:46.879533"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, absence of blast cells, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal CBC, adequate platelets, normal hemoglobin, absence of blast cells, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T20:38:46.879547"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, biopsy confirms Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, biopsy confirms Embryonal rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T20:38:46.879559"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings (clear lungs, no mass, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None needed given the negative findings. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Normal chest radiograph findings (clear lungs, no mass, normal heart size) and explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: None needed given the negative findings. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T20:38:46.879573"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Intraocular mass with calcifications, bilateral disease, positive family history, and detected RB1 germline mutation are highly suggestive of Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Intraocular mass with calcifications, bilateral disease, positive family history, and detected RB1 germline mutation are highly suggestive of Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T20:38:46.879586"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, abnormal imaging (mediastinal lymphadenopathy, bulky mass), PET-CT findings (FDG-avid nodes), and histological classification (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, abnormal imaging (mediastinal lymphadenopathy, bulky mass), PET-CT findings (FDG-avid nodes), and histological classification (Classical Hodgkin, nodular sclerosing type). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T20:38:46.879600"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension, and biopsy confirmation of Embryonal rhabdomyosarcoma. Contradicting evidence: PAX-FOXO1 fusion negative (this is a prognostic factor, not contradicting malignancy itself). Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Rhabdomyosarcoma, presence of a parameningeal mass with intracranial extension, and biopsy confirmation of Embryonal rhabdomyosarcoma. Contradicting evidence: PAX-FOXO1 fusion negative (this is a prognostic factor, not contradicting malignancy itself). Final diagnosis: Confirmed malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T20:38:46.879614"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\", \"No focal lesions\", \"Normal echo texture\", \"Benign finding\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Ultrasound findings describe physiological splenomegaly, normal echo texture, and explicitly state 'No malignancy identified'. Contradicting evidence: None identified. Alternative explanations: Splenomegaly is described as physiological for age. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on report. Supporting evidence: Ultrasound findings describe physiological splenomegaly, normal echo texture, and explicitly state 'No malignancy identified'. Contradicting evidence: None identified. Alternative explanations: Splenomegaly is described as physiological for age. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Physiological splenomegaly for age",
        "No focal lesions",
        "Normal echo texture",
        "Benign finding",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T20:38:46.879628"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\", \"Paediatric oncology assessment\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Ewing Sarcoma, permeative bone destruction, large soft tissue mass, characteristic onion-skin periosteal reaction, and positive EWSR1 fusion gene test are all highly indicative of Ewing Sarcoma, a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Ewing Sarcoma, permeative bone destruction, large soft tissue mass, characteristic onion-skin periosteal reaction, and positive EWSR1 fusion gene test are all highly indicative of Ewing Sarcoma, a malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma",
        "Paediatric oncology assessment"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T20:38:46.879644"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Findings explicitly state reactive lymphadenopathy likely due to viral infection, decreasing node size, absence of atypical features, and direct statement of 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T20:38:46.879658"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets, normal hemoglobin, and explicit statement of no malignancy identified. Contradicting evidence: None. Alternative explanations: None suggested. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets, normal hemoglobin, and explicit statement of no malignancy identified. Contradicting evidence: None. Alternative explanations: None suggested. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T20:38:46.879671"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of 'Healing fracture - normal process', and absence of 'pathological features'. Contradicting evidence: None. Alternative explanations: Healing fracture due to trauma. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified', description of 'Healing fracture - normal process', and absence of 'pathological features'. Contradicting evidence: None. Alternative explanations: Healing fracture due to trauma. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T20:38:46.879685"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Suspected Acute Lymphoblastic Leukemia\", \"Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow, immunophenotyping consistent with B-cell ALL, and clinical suspicion/diagnosis of Acute Lymphoblastic Leukemia. Contradicting evidence: CNS involvement negative (this doesn't contradict malignancy, but indicates limited spread at this point). Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of lymphoblasts (85%) in bone marrow, immunophenotyping consistent with B-cell ALL, and clinical suspicion/diagnosis of Acute Lymphoblastic Leukemia. Contradicting evidence: CNS involvement negative (this doesn't contradict malignancy, but indicates limited spread at this point). Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Suspected Acute Lymphoblastic Leukemia",
        "Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T20:38:46.879701"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on screening context. Supporting evidence: Findings indicate a resolving viral infection (likely EBV/mononucleosis) with lymphocytosis and atypical lymphocytes. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to infection. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on screening context. Supporting evidence: Findings indicate a resolving viral infection (likely EBV/mononucleosis) with lymphocytosis and atypical lymphocytes. Explicit statement 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Reactive lymphocytosis due to infection. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T20:38:46.879716"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No focal lesions\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on benign presentation. Supporting evidence: Explicit statement 'No malignancy identified', benign presentation, no focal lesions. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on benign presentation. Supporting evidence: Explicit statement 'No malignancy identified', benign presentation, no focal lesions. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign presentation",
        "No focal lesions",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T20:38:46.879728"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Findings confirm a benign lipoma with characteristics (well-circumscribed, no enhancement) inconsistent with malignancy. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history. Supporting evidence: Findings confirm a benign lipoma with characteristics (well-circumscribed, no enhancement) inconsistent with malignancy. Explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T20:38:46.879743"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass\", \"Suspected Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Suspected Wilms Tumor' and confirms 'Favorable histology on biopsy' of a 'large heterogeneous left renal mass', which is consistent with a malignant renal tumor in a pediatric patient. The staging as 'Stage II' further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Suspected Wilms Tumor' and confirms 'Favorable histology on biopsy' of a 'large heterogeneous left renal mass', which is consistent with a malignant renal tumor in a pediatric patient. The staging as 'Stage II' further supports malignancy. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass",
        "Suspected Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T20:38:46.879758"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Elevated alkaline phosphatase\", \"Suspected Osteosarcoma\", \"Paediatric oncology assessment\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, imaging findings (destructive lesion, soft tissue component, sunburst periosteal reaction), and elevated alkaline phosphatase are highly suggestive of a primary bone malignancy, specifically Osteosarcoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Osteosarcoma, imaging findings (destructive lesion, soft tissue component, sunburst periosteal reaction), and elevated alkaline phosphatase are highly suggestive of a primary bone malignancy, specifically Osteosarcoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Elevated alkaline phosphatase",
        "Suspected Osteosarcoma",
        "Paediatric oncology assessment"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T20:38:46.879774"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No previous oncology history\", \"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\", \"Reassurance provided\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on history and reason for request. Supporting evidence: History indicates a benign presentation with no prior oncology issues. MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. The healing fracture is described as a 'normal process' consistent with trauma history. Reassurance was provided. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on history and reason for request. Supporting evidence: History indicates a benign presentation with no prior oncology issues. MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. The healing fracture is described as a 'normal process' consistent with trauma history. Reassurance was provided. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign presentation",
        "No previous oncology history",
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified",
        "Reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T20:38:46.879790"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified' along with normal findings on chest radiograph (clear lungs, normal heart size, no mass). Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Explicit statement 'No malignancy identified' along with normal findings on chest radiograph (clear lungs, normal heart size, no mass). Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T20:38:46.879803"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large hepatic mass, elevated AFP (a tumor marker), and the explicit mention of 'Hepatoblastoma' (a malignant liver tumor). The fetal histology subtype and PRETEXT staging further support a malignant diagnosis. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of a large hepatic mass, elevated AFP (a tumor marker), and the explicit mention of 'Hepatoblastoma' (a malignant liver tumor). The fetal histology subtype and PRETEXT staging further support a malignant diagnosis. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T20:38:46.879818"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts 70%\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of myeloblasts (70%) in the bone marrow and the presence of a specific chromosomal translocation t(8;21), both strongly indicative of Acute Myeloid Leukemia (AML). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage of myeloblasts (70%) in the bone marrow and the presence of a specific chromosomal translocation t(8;21), both strongly indicative of Acute Myeloid Leukemia (AML). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "myeloblasts 70%",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T20:38:46.879830"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology\", \"Stage II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Wilms Tumor', a known pediatric malignancy, and describes a 'large heterogeneous left renal mass'. The staging (Stage II) and histology (Favorable) further support a diagnosis of cancer. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: The report explicitly states 'Wilms Tumor', a known pediatric malignancy, and describes a 'large heterogeneous left renal mass'. The staging (Stage II) and histology (Favorable) further support a diagnosis of cancer. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T20:38:46.879844"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage (85%) of lymphoblasts in bone marrow, immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: High percentage (85%) of lymphoblasts in bone marrow, immunophenotyping confirming B-cell ALL. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T20:38:46.879856"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Presence of intraocular mass with calcifications, bilateral disease, positive family history, and detection of RB1 germline mutation strongly suggest Retinoblastoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T20:38:46.879881"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation'. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on 'Benign presentation'. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T20:38:46.879893"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Benign bone cyst - resolved', 'No aggressive features', 'Normal bone density', 'No recurrence on imaging'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected. Supporting evidence: Report explicitly states 'No malignancy identified', 'Benign bone cyst - resolved', 'No aggressive features', 'Normal bone density', 'No recurrence on imaging'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T20:38:46.879907"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and findings. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and findings. Supporting evidence: Report explicitly states 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T20:38:46.879927"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy suspected but findings are normal. Supporting evidence: Normal brain MRI with no mass lesions or abnormal enhancement. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy suspected but findings are normal. Supporting evidence: Normal brain MRI with no mass lesions or abnormal enhancement. Contradicting evidence: None. Alternative explanations: Headaches attributed to migraine. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal brain MRI",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T20:38:46.879946"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and lack of history. Supporting evidence: MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Healing fracture is a normal process, consistent with trauma history. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - malignancy not suspected based on reason for request (screening) and lack of history. Supporting evidence: MRI findings explicitly state 'No pathological features' and 'No malignancy identified'. Contradicting evidence: None. Alternative explanations: Healing fracture is a normal process, consistent with trauma history. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T20:38:46.879964"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"palpable mass\", \"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of palpable mass, mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological confirmation of Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Clinical suspicion of Hodgkin Lymphoma, presence of palpable mass, mediastinal lymphadenopathy, bulky anterior mediastinal mass, FDG-avid nodes on PET-CT, and histological confirmation of Classical Hodgkin, nodular sclerosing type. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "palpable mass",
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T20:38:46.879986"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected based on clinical notes and imaging findings. Supporting evidence: Imaging shows an infiltrative mass with mass effect and FLAIR hyperintensity, consistent with a tumor. Biopsy confirms a diffuse astrocytoma, which is a type of brain tumor (malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected based on clinical notes and imaging findings. Supporting evidence: Imaging shows an infiltrative mass with mass effect and FLAIR hyperintensity, consistent with a tumor. Biopsy confirms a diffuse astrocytoma, which is a type of brain tumor (malignancy). Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T20:38:46.880004"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\", \"No malignancy identified\"],\n        \"rationale\": \"Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets and hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial diagnosis: NO - appears normal. Supporting evidence: Normal blood counts, absence of blast cells, adequate platelets and hemoglobin, and explicit statement 'No malignancy identified'. Contradicting evidence: None identified. Final diagnosis: Confirmed no malignancy.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T20:38:46.880021"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial diagnosis: YES - malignancy suspected. Supporting evidence: Mediastinal lymphadenopathy, bulky mass, FDG avidity, and specific histological type (Classical Hodgkin, nodular sclerosing) strongly indicate Hodgkin Lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial diagnosis: YES - malignancy suspected. Supporting evidence: Mediastinal lymphadenopathy, bulky mass, FDG avidity, and specific histological type (Classical Hodgkin, nodular sclerosing) strongly indicate Hodgkin Lymphoma. Contradicting evidence: None identified. Final diagnosis: Confirmed malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T20:38:46.880040"
    }
  ],
  "end_time": "2026-01-10T20:38:46.880308",
  "duration_seconds": 80.751086
}